REAL

Late sodium current in human, canine and guinea pig ventricular myocardium

Horváth, Balázs and Hézső, Tamás and Szentandrássy, Norbert and Kistamás, Kornél and Árpádffy-Lovas, Tamás and Varga, Richárd and Gazdag, Péter and Veress, Roland and Dienes, Csaba and Baranyai, Dóra and Almássy, János and Virág, László and Nagy, Norbert and Baczkó, István and Magyar, János and Bányász, Tamás and Varró, András and Nánási, Péter P. (2020) Late sodium current in human, canine and guinea pig ventricular myocardium. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 139. pp. 14-23. ISSN 0022-2828

[img] Text
HorvathJMCC2020.pdf
Restricted to Registered users only

Download (634kB)

Abstract

Although late sodium current (INa-late) has long been known to contribute to plateau formation of mammalian cardiac action potentials, lately it was considered as possible target for antiarrhythmic drugs. However, many aspects of this current are still poorly understood. The present work was designed to study the true profile of INa-late in canine and guinea pig ventricular cells and compare them to INa-late recorded in undiseased human hearts. INa-late was defined as a tetrodotoxin-sensitive current, recorded under action potential voltage clamp conditions using either canonic- or self-action potentials as command signals. Under action potential voltage clamp conditions the amplitude of canine and human INa-late monotonically decreased during the plateau (decrescendo-profile), in contrast to guinea pig, where its amplitude increased during the plateau (crescendo profile). The decrescendo-profile of canine INa-late could not be converted to a crescendo-morphology by application of ramp-like command voltages or command action potentials recorded from guinea pig cells. Conventional voltage clamp experiments revealed that the crescendo INa-late profile in guinea pig was due to the slower decay of INa-late in this species. When action potentials were recorded from multicellular ventricular preparations with sharp microelectrode, action potentials were shortened by tetrodotoxin, which effect was the largest in human, while smaller in canine, and the smallest in guinea pig preparations. It is concluded that important interspecies differences exist in the behavior of INa-late. At present canine myocytes seem to represent the best model of human ventricular cells regarding the properties of INa-late. These results should be taken into account when pharmacological studies with INa-late are interpreted and extrapolated to human. Accordingly, canine ventricular tissues or myocytes are suggested for pharmacological studies with INa-late inhibitors or modifiers. Incorporation of present data to human action potential models may yield a better understanding of the role of INa-late in action potential morphology, arrhythmogenesis, and intracellular calcium dynamics.

Item Type: Article
Additional Information: Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Export Date: 14 February 2020 CODEN: JMCDA Correspondence Address: Varró, A.; Department of Pharmacology and Pharmacotherapy, University of Szeged, Dóm tér 12, Hungary; email: varro.andras@med.u-szeged.hu Chemicals/CAS: tetrodotoxin, 4368-28-9, 4664-41-9 Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary Department of Basic Medical Sciences, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary Division of Sport Physiology, Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Division of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Export Date: 24 February 2020 CODEN: JMCDA Correspondence Address: Varró, A.; Department of Pharmacology and Pharmacotherapy, University of Szeged, Dóm tér 12, Hungary; email: varro.andras@med.u-szeged.hu Chemicals/CAS: tetrodotoxin, 4368-28-9, 4664-41-9 Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary Department of Basic Medical Sciences, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary Division of Sport Physiology, Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Division of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Cited By :1 Export Date: 10 July 2020 CODEN: JMCDA Correspondence Address: Varró, A.; Department of Pharmacology and Pharmacotherapy, University of Szeged, Dóm tér 12, Hungary; email: varro.andras@med.u-szeged.hu
Subjects: R Medicine / orvostudomány > RC Internal medicine / belgyógyászat
SWORD Depositor: MTMT SWORD
Depositing User: MTMT SWORD
Date Deposited: 16 Sep 2020 11:45
Last Modified: 16 Sep 2020 11:45
URI: http://real.mtak.hu/id/eprint/113445

Actions (login required)

Edit Item Edit Item